These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24022657)

  • 41. A human prostatic epithelial model of hormonal carcinogenesis.
    Wang Y; Sudilovsky D; Zhang B; Haughney PC; Rosen MA; Wu DS; Cunha TJ; Dahiya R; Cunha GR; Hayward SW
    Cancer Res; 2001 Aug; 61(16):6064-72. PubMed ID: 11507055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
    Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
    J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Next generation patient-derived prostate cancer xenograft models.
    Lin D; Xue H; Wang Y; Wu R; Watahiki A; Dong X; Cheng H; Wyatt AW; Collins CC; Gout PW; Wang Y
    Asian J Androl; 2014; 16(3):407-12. PubMed ID: 24589467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
    Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
    Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-tumour effects and pharmacokinetic profile of 17-(5'-isoxazolyl)androsta-4,16-dien-3-one (L-39) in mice: an inhibitor of androgen synthesis.
    Nnane IP; Long BJ; Ling YZ; Grigoryev DN; Brodie AM
    Br J Cancer; 2000 Jul; 83(1):74-82. PubMed ID: 10883671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
    Cordon-Cardo C; Koff A; Drobnjak M; Capodieci P; Osman I; Millard SS; Gaudin PB; Fazzari M; Zhang ZF; Massague J; Scher HI
    J Natl Cancer Inst; 1998 Sep; 90(17):1284-91. PubMed ID: 9731735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.
    Klein KA; Reiter RE; Redula J; Moradi H; Zhu XL; Brothman AR; Lamb DJ; Marcelli M; Belldegrun A; Witte ON; Sawyers CL
    Nat Med; 1997 Apr; 3(4):402-8. PubMed ID: 9095173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association of benign prostatic hyperplasia and cancer of the prostate.
    Bostwick DG; Cooner WH; Denis L; Jones GW; Scardino PT; Murphy GP
    Cancer; 1992 Jul; 70(1 Suppl):291-301. PubMed ID: 1376199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Xenografts of human benign prostatic hyperplasia tissues in the nude mouse.
    Debiec-Rychter M; Asgari K; Jones RF; Grignon DJ; Haas GP; Wang CY
    In Vivo; 1994; 8(3):449-50. PubMed ID: 7528559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
    J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer.
    Wang YZ; Wong YC
    Prostate; 1998 May; 35(3):165-77. PubMed ID: 9582085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.
    Schlechte H; Lenk SV; Löning T; Schnorr D; Rudolph BD; Ditscherlein G; Loening SA
    Eur Urol; 1998; 34(5):433-40. PubMed ID: 9803007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Relationship between benign prostatic hyperplasia and prostate cancer: new opportunities for prostate cancer chemoprevention].
    Bespalov VG; Kuzhanov AA; Vasilieva IN; Semenov AL; Alexandrov VA
    Vopr Onkol; 2016; 62(2):360-71. PubMed ID: 30462461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Whole-genome gene expression analysis in urine samples of patients with prostate cancer and benign prostate hyperplasia.
    Özdemir TR; Şimşir A; Onay H; Cüreklibatır İ; Özkınay F; Akın H
    Urol Oncol; 2017 Oct; 35(10):607.e15-607.e24. PubMed ID: 28647394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Morphogenesis of benign prostatic hyperplasia and prostatic carcinoma].
    Bonkhoff H; Remberger K
    Pathologe; 1998 Jan; 19(1):12-20. PubMed ID: 9541938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 60. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.